NCT03036384View on ClinicalTrials.gov

Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Pregnant Women
Interventions
DRUG

HB Prilocaine 2% (varying dose)

Varying dose of hyperbaric (HB) prilocaine 2% according to sensitive response of previous subjects. The dose of hyperbaric prilocaine 2% will be administrated intrathecally with 100µg of morphine and 2.5µg of sufentanyl

DRUG

HB Prilocaine 2%

The dose of 45mg of hyperbaric (HB) prilocaine 2% will be administrated intrathecally with 100µg of morphine and 2.5µg of sufentanyl

DRUG

Sufentanil

2.5µg sufentanyl

DRUG

Morphine

100 µg Morphine

Trial Locations (1)

1000

University Hospital Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels Capital Region

All Listed Sponsors
lead

Centre Hospitalier Universitaire Saint Pierre

OTHER

NCT03036384 - Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery | Biotech Hunter | Biotech Hunter